Pain Cloud® is our B2B platform using the Personalized Analgesics® in-silico network biology research
Traditional R&D
Over-reliance on non-translatable pre-clinical models, and clinical development in market-size determined patient groups that have limited links to the research target, cause the 99% failure rate
BROAD APPLICATION SPACE ALONG THE VALUE CHAIN
Pain Cloud® uses the Personalized Analgesics® research to match targets and mechanisms with the optimal patient group; e.g., allowing stratification for clinical development.
This significantly de-risks clinical development, as well as enables identifying novel applications for existing medicines, creating market extension and innovative re-purposing opportunities.
WORKING TOGETHER TO TRANSFORM HOW PAIN IS TREATED
Utilise our novel research techonolgy to increase POS of your R&D projects
-
Precisely matching targets to phenotypes;
-
Through B2B platform enabled network biology ‘diseasomics’,
-
Developing in stratified patients, selected from >1,000 conditions,
-
Creating flexible partnership structures.
